FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
|
04/01/2025 13:03:54
|
Chg.
0.000
|
Volume |
Bid13:03:54 |
Demandez à13:03:54 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
33.360EUR
|
0.00%
|
-
Chiffrre d'affaires: - |
33.360Bid taille: - |
33.600Ask la taille: - |
18.9 Mrd.EUR |
- |
- |
Description de l'entreprise
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Conseil d'administration & Conseil de surveillance
| PDG |
| Michael Sen |
| Conseil d'administration |
| Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser |
| Conseil de surveillance |
| Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Bernd Behlert , Michael Diekmann , Grit Genster , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel, Harald Steer, Oscar Romero de Paco |
Données de l'entreprise
| Nom: |
Fresenius SE & Co. KGaA |
| Adresse: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Téléphone: |
+49-6172-608-0 |
| Fax: |
- |
| Courriel: |
pr-fre@fresenius.com
|
| Internet: |
www.fresenius.de |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
56.49% |
| IPO date: |
18/12/1986 |
Relations avec les investisseurs
| Nom: |
Markus Georgi |
| Téléphone IR: |
+49-6172-608-2485 |
| IR-Fax: |
+49-6172-608-2488 |
| E-mail IR: |
ir-fre@fresenius.com
|
Calendrier de l'entreprise
|
CW 9 | 26/02/2025
Annual Report
|
|
CW 19 | 07/05/2025
Interim Report 1st Quarter/3 Months
|
|
CW 21 | 23/05/2025
General Shareholder Meeting
|
|
CW 32 | 06/08/2025
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 05/11/2025
Interim Report 3rd Quarter/9 Months
|
